Open Access
Table 1
Baseline characteristics of real-world patients. Demographics of 18 real-world patients from the TheraBionic registry. All patients had a diagnosis of advanced HCC and received treatment with HCC-specific frequencies.
| Age | Gender | Race | Previous treatment | BCLC stage | Extra hepatic mets | Child-Pugh | α-Fetoprotein ≥ 400 ng/mL | ECOG PS | POD prior to treatment |
|---|---|---|---|---|---|---|---|---|---|
| 58 | M | Caucasian | Yes | C | Yes | A5 | Yes | 1 | Yes |
| 79 | M | Caucasian | Yes | C | Yes | A6 | Yes | 1 | Yes |
| 86 | M | Caucasian | No | C | No | A5 | No | 2 | No |
| 68 | F | Caucasian | Yes | C | Yes | A6 | Yes | 2 | Yes |
| 36 | M | Caucasian | Yes | C | Yes | B8 | No | 2 | Yes |
| 84 | M | Caucasian | Yes | C | No | A6 | No | 3 | Yes |
| 74 | F | Caucasian | Yes | C | Yes | A6 | Yes | 1 | No |
| 79 | M | Caucasian | Yes | C | Yes | B9 | No | 2 | Yes |
| 63 | M | Arab / Saudi Arabia | Yes | C | Yes | C10 | Yes | 3 | Yes |
| 46 | M | Black | Yes | C | Yes | B9 | Yes | 1 | Yes |
| 76 | M | Caucasian | Yes | C | Yes | B7 | Yes | 3 | Yes |
| 70 | F | Caucasian | Yes | C | No | A6 | No | 1 | Yes |
| 46 | M | Caucasian | Yes | C | Yes | A5 | No | 1 | Yes |
| 63 | M | Caucasian | Yes | C | No | A5 | Yes | 2 | Yes |
| 74 | M | Caucasian | Yes | C | Yes | A6 | Yes | 2 | Yes |
| 75 | M | Caucasian | Yes | C | Yes | A6 | No | 2 | Yes |
| 58 | M | Caucasian | Yes | C | Yes | A6 | No | 2 | Yes |
| 72 | M | Hispanic | Yes | D | No | C11 | Yes | 2 | Yes |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.